Rafferty Asset Management
WHWK

Rafferty Asset Management’s Whitehawk Therapeutics WHWK Stock Holding History

Rafferty Asset Management’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-17,839
Closed -$220K – 1268
2022
Q2 		$220K Sell
17,839
-22,918
-56% -$340K ﹤0.01% 1029
2022
Q1 		$692K Buy
40,757
+12,790
+46% +$245K ﹤0.01% 862
2021
Q4 		$675K Buy
+27,967
New +$702K ﹤0.01% 1007

Other funds holding WHWK

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Rafferty Asset Management's WHWK Position: Q3 2022 in Review

Rafferty Asset Management sold out of Whitehawk Therapeutics (WHWK) in Q3 2022, closing a stake of 17,839 shares — an estimated $220K sold.

Rafferty Asset Management first reported a position in WHWK in Q4 2021 and held it in 3 quarters. The position peaked at $692K in Q1 2022. 68 funds tracked by Wall St. Rank hold WHWK as of Q3 2022.

  • Rafferty Asset Management reported no remaining Whitehawk Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Rafferty Asset Management sold 17,839 Whitehawk Therapeutics shares in Q3 2022, an estimated $220K.
  • Rafferty Asset Management first reported a position in Whitehawk Therapeutics in Q4 2021 and held it in 3 quarters.
  • Rafferty Asset Management's Whitehawk Therapeutics position peaked at $692K in Q1 2022.
  • 68 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q3 2022.

Based on Rafferty Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.